Literature DB >> 12683247

Therapy for meibomian gland disease.

Deval Reshma Paranjpe1, Gary N Foulks.   

Abstract

Great advances have been made in the past half-century in our understanding of meibomian gland function and of the many inflammatory, hormonal, and infectious processes leading to its dysfunction. These advances have led to an exploration of exciting new avenues for treatment of this common but frustrating disease entity.

Entities:  

Mesh：

Year:  2003        PMID： 12683247     DOI： 10.1016/s0896-1549(02)00106-2

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN： 0896-1549


  10 in total

1.  Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Shelley Kakar
Journal:  Cornea       Date:  2013-01       Impact factor: 2.651

2.  The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy.

Authors:  Yukihiro Matsumoto; Yuta Shigeno; Enrique Adan Sato; Osama M A Ibrahim; Megumi Saiki; Kazuno Negishi; Yoko Ogawa; Murat Dogru; Kazuo Tsubota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-20       Impact factor: 3.117

Review 3.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

4.  Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Sung-Hye Kim; John W McKay
Journal:  Cornea       Date:  2010-07       Impact factor: 2.651

5.  Differences in human meibum lipid composition with meibomian gland dysfunction using NMR and principal component analysis.

Authors:  Douglas Borchman; Gary N Foulks; Marta C Yappert; Sarah E Milliner
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

6.  The optimum temperature for the heat therapy for meibomian gland dysfunction.

Authors:  Douglas Borchman
Journal:  Ocul Surf       Date:  2019-02-19       Impact factor: 5.033

7.  [Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye].

Authors:  E Knop; N Knop; H Brewitt; U Pleyer; P Rieck; B Seitz; F Schirra
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

Review 8.  Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes.

Authors:  Shizuka Koh
Journal:  Clin Ophthalmol       Date:  2015-05-15

9.  Topical diquafosol for patients with obstructive meibomian gland dysfunction.

Authors:  Reiko Arita; Jun Suehiro; Tsuyoshi Haraguchi; Shuji Maeda; Koshi Maeda; Hideaki Tokoro; Shiro Amano
Journal:  Br J Ophthalmol       Date:  2013-04-12       Impact factor: 4.638

Review 10.  Emerging treatment options for meibomian gland dysfunction.

Authors:  Jing Qiao; Xiaoming Yan
Journal:  Clin Ophthalmol       Date:  2013-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.